Franklin Biotechnology Disc A Acc $

Performance History31/12/2014
Growth of 1,000 (EUR)
Franklin Biotechnology Disc A Acc $
Fund25.813.324.957.253.4
+/-Cat8.211.40.26.04.9
+/-Idx15.8-5.6-16.9-3.34.5
 
Key Stats
NAV
28/01/2015
 USD 32.83
Day Change -2.24%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
31/12/2014
 USD 2529.87
Share Class Size (Mil)
31/12/2014
 USD 2037.34
Max Initial Charge 5.75%
Ongoing Charge
16/01/2015
  1.81%
Investment Objective: Franklin Biotechnology Disc A Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns28/01/2015
YTD11.59
3 Years Annualised44.97
5 Years Annualised35.26
10 Years Annualised17.55
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Jerel Banks
01/09/2012
Inception Date
03/04/2000
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Disc A Acc $31/10/2014
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks97.670.0097.67
Bonds0.000.000.00
Cash2.340.002.34
Other0.000.000.00
Top 5 Regions%
United States95.50
United Kingdom2.78
Eurozone0.95
Canada0.60
Europe - ex Euro0.16
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare10.06
Gilead Sciences IncHealthcareHealthcare8.32
Biogen Idec IncHealthcareHealthcare6.71
Amgen IncHealthcareHealthcare5.53
Medivation IncHealthcareHealthcare3.80
Franklin Biotechnology Disc A Acc $